Tag: Kidney disease
University of Florida Diabetes Institute to Establish Novel Biobank to Study Kidney and Cardiovascular...
A major step toward transforming the understanding of cardiovascular and kidney disease in the millions of Americans with diabetes occurred Thursday when the National Institutes of Health designated the University of Florida Diabetes Institute the home for a new biobank...
Evotec to Partner with GCKD Study to Facilitate Molecular Analysis of Patient Samples
Evotec SE and the University Hospital Erlangen just announced a partnership regarding molecular analyses of biospecimens from the German Chronic Kidney Disease ("GCKD") cohort study. Under the agreement, the research team will make use of Evotec's proprietary EVOpanOmics and EVOpanHunter platforms to...
Serum Uric Acid Predicts Kidney Cancer Incidence
According to the US Surveillance, Epidemiology, and End Results program, the outlook for kidney cancer patients is generally favourable with an overall five year survival rate of 77%, furthermore the survival rate in the 65-74 age category is still...
Kidney Injury After Heart Surgery – A Japan National Center Biobank Network Investigation
Sudden injury to the kidneys or acute kidney injury (AKI) in which waste excretion into urine is impaired can occur as a result of a multitude of shocks to the body including sepsis and cardiac surgery. The presence of...
Biobank Investigation Of Gut Methanogens In Kidney Transplant Recipients
Kidney transplant is a common procedure in those with
late-stage renal disease. These patients can experience gastrointestinal
complaints such as diarrhea, which may be associated with premature kidney
allograft failure and mortality. Historically, has been thought due to
medication, however the etiology is...
RenalytixAI To Validate KidneyIntelX™ In Collaboration With University Medical Center Groningen
Renalytix AI plc, a developer of artificial
intelligence-enabled clinical diagnostics for kidney disease, has announced a
collaboration with University Medical Center Groningen (UMCG), Netherlands, to
evaluate KidneyIntelX™ across over 3,500 patients with Type II Diabetes. The
study will assess how effectively KidneyIntelX identifies...
RenalytixAI Begins Clinical Validation Of KidneyIntelX™ Built From The Mount Sinai BioMe™ BioBank
RenalytixAI plc., has announced the start of its clinical validation study for its lead diagnostic, 𝘒𝘪𝘥𝘯𝘦𝘺𝘐𝘯𝘵𝘦𝘭𝘟™. It is designed to diagnose and improve the clinical management of patients with Type II diabetes and those of African ancestry with fast-progressing...
Biobanking Science: Biobanks Tackle Chronic Kidney Disease
Chronic kidney disease is common. The prevalence of chronic kidney disease has rapidly increased over the past 20 years, and it now affects 13% of people around the world (1). Chronic kidney disease can be difficult to treat because...
The REDinREN Biobank
Established in 2007, the REDinREN Biobank is a non-profit organisation that hosts a large collection of samples for kidney disease biomedical research. It specialises in quality, order and distribution. It is housed at the University of Alcalá, Madrid, Spain...
